Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Cornea. 2015 Mar;34(3):243–247. doi: 10.1097/ICO.0000000000000340

Table 1.

Time Between Hematopoietic Stem Cell Transplant and Onset of Ocular GVHD

Donor-Recipient
Characteristics
No. (%) Median time between
Allo-HSCT and ocular
GVHD in days (months)
Range
(Days)
Interquartile
range
(Days)
5/6 HLA-match 29 (16) 219 (7) 26-621 153-348
6/6 HLA-match 150 (84) 294 (10) 28-2308 223-506
Matched-Related 66 (36.9) 307 (10) 87-2308 241-577
Matched-Unrelated 84 (47.0) 286 (9) 28-1418 207-447
Mismatched-Unrelated 28 (15.6) 231 (8) 26-621 153-348
Mismatched-Related 1 (0.5) - - -

GVHD = Graft-versus-host disease; HLA = Human Leucocyte Antigen; Matched = 6/6 HLA match; Mismatched = 5/6 HLA-match